|
|
Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook
Business Insights Diagnostics reports are aimed at decision
makers within the diagnostics, pharmaceutical, biotech or
associated healthcare industries. They give executives an
in-depth understanding of the diagnostics industry and its
convergence with the pharmaceutical industry. Cutting edge
technologies will be assessed based on their ability to
influence the size and direction of the market.
The diagnostics market was valued at $35bn in 2008 and continues
to experience steady growth. Diagnostics is becoming
increasingly integrated with the pharmaceutical industry with
moves to develop personalized medicine being dependent upon the
development of dedicated diagnostic techniques. This series of
reports aims to bridge the gap in our portfolio of healthcare
reports to cover this already vital and increasingly important
sector of the healthcare industry.
Within the diagnostics environment there are two main
industries; medical imaging and in-vitro diagnostics. These two
industries have in the past been relatively separate although
recently there has been a trend towards convergence between the
two as novel technologies are developed which utilize elements
of both molecular science and imaging technology.
Microarrays and biochips are small devices capable of detecting
and measuring large numbers of biomarkers simultaneously.
Although microarrays have been in research use for over a decade
it is only recently that they have moved towards meeting the
requirements of the clinical and regulatory communities with the
first DNA microarray test being approved by the US FDA in 2007.
Further development of microarrays heralds the introduction of
faster diagnosis times and will further enable personalized
medicine. This report covers future developments in key segments
of the microarray market including DNA, protein, tissue and cell
microarrays and lab-on-a-chip technologies, providing market
forecasts to 2013. In addition the report gives insights into
the developmental programs of 45 leading players in this market.
View
Table Of Contents >
|
